Alteration of complement protein levels after antiretroviral therapy in HIV-infected persons

AIDS Res Hum Retroviruses. 1999 Dec 10;15(18):1713-5. doi: 10.1089/088922299309766.
No abstract available

Publication types

  • Clinical Trial
  • Letter
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Anti-HIV Agents / administration & dosage
  • Anti-HIV Agents / therapeutic use*
  • Complement Pathway, Classical*
  • Complement System Proteins / analysis*
  • Drug Administration Schedule
  • Drug Therapy, Combination
  • HIV Antibodies / immunology
  • HIV Antigens / immunology
  • HIV Infections / blood
  • HIV Infections / drug therapy*
  • HIV Infections / immunology
  • HIV Protease Inhibitors / administration & dosage
  • HIV Protease Inhibitors / therapeutic use*
  • Humans
  • Lamivudine / administration & dosage
  • Lamivudine / therapeutic use*
  • Reverse Transcriptase Inhibitors / administration & dosage
  • Reverse Transcriptase Inhibitors / therapeutic use*
  • Ritonavir / therapeutic use*
  • Viral Load
  • Zidovudine / therapeutic use*

Substances

  • Anti-HIV Agents
  • HIV Antibodies
  • HIV Antigens
  • HIV Protease Inhibitors
  • Reverse Transcriptase Inhibitors
  • Lamivudine
  • Zidovudine
  • Complement System Proteins
  • Ritonavir